UBS Evidence Lab Uses Hospital Data to Profile Regional Recoveries

The unit is combining foot-traffic data and proprietary datasets derived from hospitals to develop a better understanding of outbreaks and predict a timeline for recovery.

How Covid‑19 is impacting transition preparations

At the beginning of the pandemic, geolocation data played a key role in measuring the outbreak of the Covid-19 disease, and provided something of a warning system for firms as to where the next series of lockdowns were most likely to unfold.

While geolocation data is still being used to monitor for second- and third-wave outbreaks, it is also being used to highlight a return of business for regional hospitals, says Jeremy Brunelli, global head of frameworks at UBS Evidence Lab, the independent

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

If you already have an account, please sign in here.

Brown Brothers Harriman unifies busy suite of AI products

It’s a new world, contend BBH’s Kevin Welch and Josh Fine. After a few years of experimentation that yielded several AI products for the bank and its clients, it was time to put the puzzle pieces together to serve a different way of working post-Covid.

Bank-backed Versana takes aim at syndicated loan tech

Born from a consortium that includes JP Morgan and Bank of America, Versana aims to bring up-to-date and permissioned data to the syndicated loan market—the first step to a more transparent and faster operating market.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: